RE:RE:RE:RE:Phase II ACT-NMIBC studyIt's been 5 years since they started the mouse trials. Investors are asking where's the money? That's what you need to discuss. I remember when predictions of a $3 sp were made just on news of a HC approval to start the phase 1b trial. Here we are years later with 2 patients showing no cancer after 12 months and the sp is still just 52 pennies with no major media exposure. Correct me if I'm wrong but isn't all about the money?